Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.

被引：0
|
作者：
Maynard, M
Ahmed, SNS
Bailly, F
Rozier, F
Benmakhlouf, N
Bourne-Branchu, V
Fazly, T
Nemoz, C
Adeleine, P
Pradat, P
Trepo, C
机构：
[1] Hop Hotel Dieu, Lyon, France
[2] Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：398A / 398A
页数：1
相关论文
共 50 条
  • [1] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
  • [2] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    World Journal of Gastroenterology, 2005, (04) : 580 - 583
  • [3] Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Milella, M
    Santantonio, T
    Pietromatera, G
    Maselli, R
    Casalino, C
    Mariano, N
    Genchi, C
    Pastore, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 211 - 215
  • [4] Retreatment of standard interferon/ribavirin non-responder patients with chronic hepatitis C with daily consensus interferon and ribavirin yields high sustained response rates.
    Kaiser, S
    Hass, HG
    Gregor, M
    HEPATOLOGY, 2003, 38 (04) : 276A - 276A
  • [5] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients
    Bernstein, DE
    Jeffers, LJ
    Lake-Bakaar, G
    Reddy, KR
    Schiff, ER
    GASTROENTEROLOGY, 1999, 116 (04) : A1190 - A1190
  • [6] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.
    Bernstein, DE
    Khan, R
    Jeffers, LJ
    Reddy, KR
    Schiff, ER
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [7] Ribavirin plus IFN vs IFN alone in the retreatment of IFN non responder patients with chronic hepatitis C.
    Pastore, G
    Milella, M
    Santantonio, T
    Pietromatera, G
    De Lee, M
    Tricarico, D
    Tisci, A
    Carlone, R
    Casalino, C
    Genchi, C
    HEPATOLOGY, 2000, 32 (04) : 464A - 464A
  • [8] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Stauber, RE
    Hofer, H
    Hackl, F
    Schütze, K
    Datz, C
    Hegenbarth, K
    Jessner, W
    Steindl-Munda, P
    Ferenci, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (15-16) : 530 - 535
  • [9] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Rudolf E Stauber
    Harald Hofer
    Franz Hackl
    Kurt Schüze
    Christian Datz
    Karin Hegenbarth
    Wolfgang Jessner
    Petra Steindl-Munda
    Peter Ferenci
    Wiener Klinische Wochenschrift, 2004, 116 : 530 - 535
  • [10] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
12345